Evidence map›Paper›PMID 40638670›Full record

ArticlePloS one2025

Factors associated with death from COVID-19 in traditional peoples and communities in Brazil.

Sebastião Bruno Taveira Silva, Audêncio Victor, Ana Raquel Ernesto Manuel Gotine, Dalva Maria de Assis, Marcelo Yoshito Wada, Greice Madeleine Ikeda do Carmo, Luciana Nogueira de Almeida Guimarães, Eucilene Alves Santana

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Sebastião Bruno Taveira SilvaMinistry of Health, Secretariat of Health Surveillance and Environment, General Coordination of Immunopreventable Diseases Surveillance (CGVDI), Brasília, DF, Brazil.
Audêncio VictorSchool of Public Health, University of São Paulo (USP), Department of Public Health, São Paulo, SP, Brasil.ORCID https://orcid.org/0000-0002-8161-3639
Ana Raquel Ernesto Manuel GotineSchool of Public Health, University of São Paulo (USP), Department of Public Health, São Paulo, SP, Brasil.ORCID https://orcid.org/0000-0002-3539-4236
Dalva Maria de AssisMinistry of Health, Secretariat of Health Surveillance and Environment, General Coordination of Immunopreventable Diseases Surveillance (CGVDI), Brasília, DF, Brazil.ORCID https://orcid.org/0000-0002-3102-7607
Marcelo Yoshito WadaMinistry of Health, Secretariat of Health Surveillance and Environment, General Coordination of Immunopreventable Diseases Surveillance (CGVDI), Brasília, DF, Brazil.
Greice Madeleine Ikeda do CarmoMinistry of Health, Secretariat of Health Surveillance and Environment, General Coordination of Immunopreventable Diseases Surveillance (CGVDI), Brasília, DF, Brazil.
Luciana Nogueira de Almeida GuimarãesMinistry of Health, Secretariat of Health Surveillance and Environment, General Coordination of Immunopreventable Diseases Surveillance (CGVDI), Brasília, DF, Brazil.
Eucilene Alves SantanaMinistry of Health, Secretariat of Health Surveillance and Environment, General Coordination of Immunopreventable Diseases Surveillance (CGVDI), Brasília, DF, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCOVID-19 has disproportionately impacted vulnerable populations, including traditional communities in Brazil, who face socioeconomic and health disparities, increasing the risk of severe outcomes. This study aims to identify factors associated with mortality among hospitalized COVID-19 patients from traditional communities in Brazil.

methodsThis cross-sectional study analyzed data from the System of Epidemiological Surveillance of Influenza (SIVEP-Gripe) on hospitalizations for COVID-19 between 2021 and 2023. Individuals from traditional communities were included. The variables analyzed included demographic characteristics, clinical symptoms, comorbidities, and the need for hospital support. Logistic regressions were performed to assess associations with mortality, considering p < 0.05 significant.

resultsOf the 7,101 cases analyzed, males showed a higher risk of death (OR = 1.39; 95% CI: 1.18-1.63). Among ethnic groups, blacks presented with an OR = 2.92 (95% CI: 1.68-5.08) and indigenous, OR = 2.25 (95% CI: 1.73-2.94). Older age increased the risk, with OR = 6.57 (95% CI: 2.16-28.5) for ages 60-79 and OR = 12.8 (95% CI: 4.18-55.8) for ≥80 years. Dyspnea (OR = 2.16; 95% CI: 1.77-2.65) and low saturation (OR = 2.13; 95% CI: 1.78-2.55) were associated with death, while loss of taste was protective (OR = 0.62; 95% CI: 0.51-0.75). Immunosuppression (OR = 2.14; 95% CI: 1.23-3.79) and chronic renal disease (OR = 1.64; 95% CI: 1.10-2.46) increased the risk. Patients on invasive ventilation had the highest risk of death (OR = 19.4; 95% CI: 15.2-25.0), followed by non-invasive ventilation (OR = 2.65; 95% CI: 2.18-3.23) and ICU (OR = 2.15; 95% CI: 1.85-2.49).

conclusionRisk factors for mortality among hospitalized patients from traditional communities include male sex, older age, race/color, severe respiratory symptoms, comorbidities, and the need for invasive ventilation. These findings reinforce the importance of targeted health strategies to reduce the risk of mortality in these vulnerable populations.

Indexed as

COVID-19AdolescentAdultAgedAged, 80 and overBrazilComorbidityCross-Sectional StudiesFemaleHospitalizationHumansMaleMiddle AgedRisk FactorsSARS-CoV-2Young Adult

Identifiers

PMID40638670
PMCPMC12244660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.